author-photo

Ann-Christin Arfwidsson

AstraZeneca

2

Papers

133

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

A dose-ranging study of the oral direct thrombin inhibitor, ximelagatran, and its subcutaneous form, melagatran, compared with dalteparin in the prophylaxis of thromboembolism after hip or knee replacement: METHRO I

2002 Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (118)
Prophylaxis of venous thromboembolism with subcutaneous melagatran in total hip or total knee replacement: results from Phase II studies.

2002 Thrombosis Research
Show All
- Source
- Cite
- Save
Citations (15)